Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 39,222 | 59,237 | 27,387 | 23,559 | 24,120 |
| Operating Income | -39,222 | -59,237 | -27,387 | -23,559 | -24,120 |
| Interest Expense | 1,729 | 1,641 | 1,967 | 1,786 | 1,573 |
| Other Income | 772 | -38 | 274 | 305 | 1,029 |
| Pre-tax Income | -40,179 | -60,916 | -29,080 | -25,040 | -24,664 |
| Net Income Continuous | -40,179 | -60,916 | -29,080 | -25,040 | -24,664 |
| Net Income | $-40,179 | $-60,916 | $-29,080 | $-25,040 | $-24,664 |
| EPS Basic Total Ops | -0.65 | -1.09 | -0.53 | -0.45 | -0.45 |
| EPS Basic Continuous Ops | -0.65 | -1.09 | -0.53 | -0.45 | -0.45 |
| EPS Diluted Total Ops | -0.65 | -1.09 | -0.53 | -0.45 | -0.45 |
| EPS Diluted Continuous Ops | -0.65 | -1.09 | -0.53 | -0.45 | -0.45 |
| EBITDA(a) | $-38,548 | $-52,922 | $-27,114 | $-23,435 | $-24,002 |